Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study

Detalhes bibliográficos
Autor(a) principal: Ponce, Daniela [UNESP]
Data de Publicação: 2022
Outros Autores: Zamoner, Welder [UNESP], Magalhães, Luis Eduardo [UNESP], de Oliveira, Paula Gabriela Sousa [UNESP], Polla, Patricia [UNESP], Barbosa, Alexandre Naime [UNESP], de Assis Golim, Marjorie [UNESP], Snr, André Luís Balbi [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
DOI: 10.2147/IJNRD.S382776
Texto Completo: http://dx.doi.org/10.2147/IJNRD.S382776
http://hdl.handle.net/11449/246220
Resumo: Background: In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option for cytokine removal. Objective: This study aimed to describe and compare cytokine removal during intermittent haemodialysis (IHD) and continuous renal replacement therapy (CRRT) in COVID-19 patients with Acute Kidney Injury (AKI). Methods: It was a cohort study that studied patients with COVID-19-related AKI according to KDIGO criteria and admitted at Intensive Care Unit (ICU). Blood samples were collected at the start and end of both IHD using high flux (HF) membranes (10 patients) and continuous venovenous haemodiafiltration (CVVHDF:10 patients) in two sessions for measuring 13 different plasma interleukins and calculating the cytokine removal rate. Results: There was no difference between the two groups regarding mechanical ventilation, vasoactive drug, age or prognostic scores. Patients treated by CRRT presented higher levels of IL-2 and IL-8 than patients treated by IHD at dialysis start. Cytokine removal ranged from 9% to 78%. Patients treated by CRRT presented higher cytokine removal for IL-2, IL-6 IL-8, IP-10 and TNF. The removal rates of IL-4, IL-10, IL-17A, IFN, MCP-1 and TGF-B1 were similar in two groups. After one session of CVVHDF (24 h), IL-2 and IL-1β levels did not vary significantly, whereas IL-4, IL-6, IL-8, IL-10, IL-17A, TNF, IFN, IP-10, MCP-1, IL-12p70 and TGF-B1 decreased by 33.8–76%, and this decrease was maintained over the next 24 h. In IHD groups, IL-2, IL-6, TNF, IP-10 and IL-1β levels did not decrease significantly whereas IL-4, IL-8, IL-10, IL-17A, IFN, MCP-1, IL-12p70 and TGF-B1 decreased by 21.8–72%; however, cytokine levels returned to their initial values after 24 h. Conclusion: Cytokine removal is lower in IHD using HF membranes than in CVVHDF, and in IHD the removal is transient and selective, which can be associated with mortality during cytokines storm-related COVID-19.
id UNSP_483c6d630ad003387a3b40e140d567b2
oai_identifier_str oai:repositorio.unesp.br:11449/246220
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Studycytokine stormEBPremovalBackground: In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option for cytokine removal. Objective: This study aimed to describe and compare cytokine removal during intermittent haemodialysis (IHD) and continuous renal replacement therapy (CRRT) in COVID-19 patients with Acute Kidney Injury (AKI). Methods: It was a cohort study that studied patients with COVID-19-related AKI according to KDIGO criteria and admitted at Intensive Care Unit (ICU). Blood samples were collected at the start and end of both IHD using high flux (HF) membranes (10 patients) and continuous venovenous haemodiafiltration (CVVHDF:10 patients) in two sessions for measuring 13 different plasma interleukins and calculating the cytokine removal rate. Results: There was no difference between the two groups regarding mechanical ventilation, vasoactive drug, age or prognostic scores. Patients treated by CRRT presented higher levels of IL-2 and IL-8 than patients treated by IHD at dialysis start. Cytokine removal ranged from 9% to 78%. Patients treated by CRRT presented higher cytokine removal for IL-2, IL-6 IL-8, IP-10 and TNF. The removal rates of IL-4, IL-10, IL-17A, IFN, MCP-1 and TGF-B1 were similar in two groups. After one session of CVVHDF (24 h), IL-2 and IL-1β levels did not vary significantly, whereas IL-4, IL-6, IL-8, IL-10, IL-17A, TNF, IFN, IP-10, MCP-1, IL-12p70 and TGF-B1 decreased by 33.8–76%, and this decrease was maintained over the next 24 h. In IHD groups, IL-2, IL-6, TNF, IP-10 and IL-1β levels did not decrease significantly whereas IL-4, IL-8, IL-10, IL-17A, IFN, MCP-1, IL-12p70 and TGF-B1 decreased by 21.8–72%; however, cytokine levels returned to their initial values after 24 h. Conclusion: Cytokine removal is lower in IHD using HF membranes than in CVVHDF, and in IHD the removal is transient and selective, which can be associated with mortality during cytokines storm-related COVID-19.Department of Internal Medicine University Estadual Paulista (UNESP), São PauloClinical Hospital of Botucatu Medical School, São PauloDepartment of Infectious Disease University Estadual Paulista (UNESP), São PauloDepartment of Internal Medicine University Estadual Paulista (UNESP), São PauloClinical Hospital of Botucatu Medical School, São PauloDepartment of Infectious Disease University Estadual Paulista (UNESP), São PauloUniversidade Estadual Paulista (UNESP)Ponce, Daniela [UNESP]Zamoner, Welder [UNESP]Magalhães, Luis Eduardo [UNESP]de Oliveira, Paula Gabriela Sousa [UNESP]Polla, Patricia [UNESP]Barbosa, Alexandre Naime [UNESP]de Assis Golim, Marjorie [UNESP]Snr, André Luís Balbi [UNESP]2023-07-29T12:34:57Z2023-07-29T12:34:57Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article309-317http://dx.doi.org/10.2147/IJNRD.S382776International Journal of Nephrology and Renovascular Disease, v. 15, p. 309-317.1178-7058http://hdl.handle.net/11449/24622010.2147/IJNRD.S3827762-s2.0-85141081571Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengInternational Journal of Nephrology and Renovascular Diseaseinfo:eu-repo/semantics/openAccess2023-07-29T12:34:57Zoai:repositorio.unesp.br:11449/246220Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T17:42:00.575772Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
title Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
spellingShingle Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
Ponce, Daniela [UNESP]
cytokine storm
EBP
removal
Ponce, Daniela [UNESP]
cytokine storm
EBP
removal
title_short Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
title_full Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
title_fullStr Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
title_full_unstemmed Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
title_sort Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
author Ponce, Daniela [UNESP]
author_facet Ponce, Daniela [UNESP]
Ponce, Daniela [UNESP]
Zamoner, Welder [UNESP]
Magalhães, Luis Eduardo [UNESP]
de Oliveira, Paula Gabriela Sousa [UNESP]
Polla, Patricia [UNESP]
Barbosa, Alexandre Naime [UNESP]
de Assis Golim, Marjorie [UNESP]
Snr, André Luís Balbi [UNESP]
Zamoner, Welder [UNESP]
Magalhães, Luis Eduardo [UNESP]
de Oliveira, Paula Gabriela Sousa [UNESP]
Polla, Patricia [UNESP]
Barbosa, Alexandre Naime [UNESP]
de Assis Golim, Marjorie [UNESP]
Snr, André Luís Balbi [UNESP]
author_role author
author2 Zamoner, Welder [UNESP]
Magalhães, Luis Eduardo [UNESP]
de Oliveira, Paula Gabriela Sousa [UNESP]
Polla, Patricia [UNESP]
Barbosa, Alexandre Naime [UNESP]
de Assis Golim, Marjorie [UNESP]
Snr, André Luís Balbi [UNESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
dc.contributor.author.fl_str_mv Ponce, Daniela [UNESP]
Zamoner, Welder [UNESP]
Magalhães, Luis Eduardo [UNESP]
de Oliveira, Paula Gabriela Sousa [UNESP]
Polla, Patricia [UNESP]
Barbosa, Alexandre Naime [UNESP]
de Assis Golim, Marjorie [UNESP]
Snr, André Luís Balbi [UNESP]
dc.subject.por.fl_str_mv cytokine storm
EBP
removal
topic cytokine storm
EBP
removal
description Background: In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option for cytokine removal. Objective: This study aimed to describe and compare cytokine removal during intermittent haemodialysis (IHD) and continuous renal replacement therapy (CRRT) in COVID-19 patients with Acute Kidney Injury (AKI). Methods: It was a cohort study that studied patients with COVID-19-related AKI according to KDIGO criteria and admitted at Intensive Care Unit (ICU). Blood samples were collected at the start and end of both IHD using high flux (HF) membranes (10 patients) and continuous venovenous haemodiafiltration (CVVHDF:10 patients) in two sessions for measuring 13 different plasma interleukins and calculating the cytokine removal rate. Results: There was no difference between the two groups regarding mechanical ventilation, vasoactive drug, age or prognostic scores. Patients treated by CRRT presented higher levels of IL-2 and IL-8 than patients treated by IHD at dialysis start. Cytokine removal ranged from 9% to 78%. Patients treated by CRRT presented higher cytokine removal for IL-2, IL-6 IL-8, IP-10 and TNF. The removal rates of IL-4, IL-10, IL-17A, IFN, MCP-1 and TGF-B1 were similar in two groups. After one session of CVVHDF (24 h), IL-2 and IL-1β levels did not vary significantly, whereas IL-4, IL-6, IL-8, IL-10, IL-17A, TNF, IFN, IP-10, MCP-1, IL-12p70 and TGF-B1 decreased by 33.8–76%, and this decrease was maintained over the next 24 h. In IHD groups, IL-2, IL-6, TNF, IP-10 and IL-1β levels did not decrease significantly whereas IL-4, IL-8, IL-10, IL-17A, IFN, MCP-1, IL-12p70 and TGF-B1 decreased by 21.8–72%; however, cytokine levels returned to their initial values after 24 h. Conclusion: Cytokine removal is lower in IHD using HF membranes than in CVVHDF, and in IHD the removal is transient and selective, which can be associated with mortality during cytokines storm-related COVID-19.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
2023-07-29T12:34:57Z
2023-07-29T12:34:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.2147/IJNRD.S382776
International Journal of Nephrology and Renovascular Disease, v. 15, p. 309-317.
1178-7058
http://hdl.handle.net/11449/246220
10.2147/IJNRD.S382776
2-s2.0-85141081571
url http://dx.doi.org/10.2147/IJNRD.S382776
http://hdl.handle.net/11449/246220
identifier_str_mv International Journal of Nephrology and Renovascular Disease, v. 15, p. 309-317.
1178-7058
10.2147/IJNRD.S382776
2-s2.0-85141081571
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv International Journal of Nephrology and Renovascular Disease
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 309-317
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1822182400579338240
dc.identifier.doi.none.fl_str_mv 10.2147/IJNRD.S382776